Prostatic Neoplasms  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00427999 / 2006-000218-19: Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer

Checkmark Data
May 2011 - May 2011: Data
Completed
2
67
Europe
imatinib mesylate, Gleevec, Glivec, Treosulfane, Ovastat, etoricoxib, Arcoxia, pioglitazone, Actos, dexamethasone, Fortecortin
Novartis Pharmaceuticals
Prostate Cancer
06/15
08/15

Download Options